The research team, led by pediatric cardiologist Margarita Zapata-Sánchez of Clínica Cardio VID in Medellín, Colombia, together with colleagues from the Fundación Cardiovascular de Colombia, examined twenty years of surgical experience across two specialized cardiovascular centers. They assembled a consecutive cohort of fifty-one children who underwent repair of an anomalous coronary artery origin, then divided the patients into three groups according to how the disease announced itself: those who were asymptomatic and discovered incidentally, those who arrived in acute heart failure, and those living with compensated chronic heart failure. The question was simple but clinically important. Does a heart that has been pushed into overt failure before surgery recover as well as one that was caught before symptoms appeared?

To answer it, the investigators tracked the left ventricular ejection fraction, or LVEF, the standard measure of how forcefully the heart’s main pumping chamber squeezes blood out with each beat. A healthy ventricle ejects more than half of the blood it contains with every contraction. In children with ALCAPA, chronic oxygen deprivation, or myocardial ischemia, can drive that number down dramatically, producing ventricular dysfunction, mitral valve leakage, and heart failure. The study’s primary outcome was the change in LVEF between the preoperative assessment and hospital discharge, a window that captures the earliest and most demanding phase of recovery, when the heart must adapt immediately after being reconnected to a proper arterial blood supply.

The distribution of clinical presentations tells its own story about how this defect behaves. Just over a quarter of the children, twenty-seven percent, were asymptomatic at diagnosis, meaning their anomaly was found without warning signs. More than half, fifty-one percent, presented with acute heart failure, often the dramatic first manifestation of the disease in infancy. The remaining twenty-two percent had chronic, compensated heart failure, a slower-burning form in which the heart and body have partially adapted to the chronic ischemia. Anomalous left coronary artery from the pulmonary artery accounted for ninety-two percent of all cases in the cohort, confirming that this variant dominates the spectrum of anomalous coronary origins from the pulmonary circulation in children.

Not surprisingly, the children who presented with heart failure arrived at the operating table in worse shape. The study documented more advanced preoperative disease and greater requirements for medical and mechanical support in these patients compared with their asymptomatic counterparts. Their ventricles were weaker, their physiology more fragile, and their perioperative course more demanding. This gradient of severity is exactly what the pathophysiology predicts: the longer the heart muscle is deprived of adequate coronary perfusion, the more extensive the injury, and the harder the recovery. What remained uncertain before this study was whether that preoperative damage would leave a lasting imprint on postoperative ventricular performance.

The surgical repair itself, in most cases, involved coronary reimplantation, which was used in nearly sixty-nine percent of patients. The technique involves detaching the anomalous coronary artery from the pulmonary artery and reattaching it directly to the aorta, restoring the normal dual-coronary anatomy and re-establishing high-pressure, oxygen-rich perfusion to the heart muscle. This is the operation that effectively reverses the fundamental defect: instead of stealing blood from the heart through the low-pressure pulmonary vessel, the coronary artery once again receives blood pushed into it by the aorta during diastole, the relaxation phase of the cardiac cycle when coronary filling normally occurs.

The results were unambiguous on the central question. Left ventricular ejection fraction improved significantly after surgery across the entire cohort, and by the time of hospital discharge it had normalized in all three presentation groups. When the researchers compared postoperative LVEF among the asymptomatic, acute heart failure, and chronic heart failure groups, they found no statistically significant differences, with a p-value of 0.918, essentially indicating that the groups were indistinguishable on this measure. Overall, recovery of ventricular function, defined as an ejection fraction above fifty percent, was achieved in eighty-six percent of patients. In other words, a heart that had been failing before surgery was, in most cases, pumping normally again within weeks of the operation, just like the hearts of children whose defects had been caught early.

But the study also delivered a sobering counterpoint. Although ventricular recovery was similar across groups, the children who had presented with heart failure paid a price in the immediate postoperative period. They experienced greater morbidity, meaning more complications and a more difficult convalescence, and they required longer hospitalizations. The heart muscle may forgive, but the body remembers the assault of preoperative failure. This finding reframes the clinical calculus: surgery restores pumping function with impressive consistency, yet the route a child takes to the operating room determines how rocky the road afterward will be. Early diagnosis does not change the destination of ventricular recovery, but it dramatically shortens and smooths the journey.

That message carries real weight for pediatric practice, particularly in regions where access to specialized cardiac care can be uneven. ALCAPA is rare, and its symptoms in infants, including poor feeding, sweating, irritability, and respiratory distress, can mimic far more common childhood illnesses, which delays diagnosis. The Latin American data underscore that every week of undetected ischemia increases the likelihood that a child will present in acute heart failure, with all the associated perioperative risks. The study’s authors argue that their findings highlight the importance of early diagnosis and timely surgical intervention, and the numbers bear that out: the asymptomatic group enjoyed the same excellent ventricular recovery as everyone else, but without the burden of extended hospital stays and postoperative complications.

The study also demonstrates the value of regional, multicenter collaboration in studying rare diseases. No single center sees enough cases of anomalous coronary artery origin to draw firm conclusions, but by pooling two decades of consecutive patients from two Latin American referral centers, the investigators produced a cohort large enough to compare outcomes across clinical presentations with genuine statistical power. The work was conducted under ethical approval from the Fundación Cardiovascular de Colombia and received no external funding. For the children of the region, and for clinicians everywhere who face this elusive diagnosis, the study provides reassurance that the pediatric heart possesses a striking capacity for recovery once its blood supply is restored, and a clear argument for finding the defect before it finds the child.

Subject of Research: Recovery of left ventricular function in children after surgical repair of anomalous coronary artery origin from the pulmonary artery

Article Title: Recovery of left ventricular function in children following repair of anomalous coronary artery origin according to clinical presentation: a multicenter study from Latin America

Article References: Recovery of left ventricular function in children following repair of anomalous coronary artery origin according to clinical presentation: a multicenter study from Latin America. (n.d.). https://doi.org/10.1186/s12887-026-07713-6

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07713-6

Keywords: anomalous coronary artery origin, ALCAPA, left ventricular ejection fraction, pediatric cardiac surgery, congenital heart defects, heart failure, myocardial ischemia, coronary reimplantation, ventricular recovery, Latin America, BMC Pediatrics, early diagnosis